METABOLIC CONVERSION OF PRIMIDONE (MYSOLINE) TO PHENOBARBITONE IN PATIENTS UNDER LONG-TERM TREATMENT - AN ATTEMPT TO ESTIMATE INDEPENDENT EFFECT OF PRIMIDONE

被引：47

作者：

OLESEN, OV

DAM, M

机构：

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1967年 / 43卷 / 03期

关键词：

D O I：

10.1111/j.1600-0404.1967.tb05737.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：348 / +

页数：1

共 21 条

[1] THE EVALUATION OF MYSOLINE - A NEW ANTICONVULSANT DRUG [J].

BOGUE, JY ;

CARRINGTON, HC .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1953, 8 (02) :230-236

[2]

BOGUE JY, 1956, ACTA NEUROL BELG, V56, P640

[3]

BURTONBRADLEY BG, 1953, MED J AUSTRALIA, V40, P705

[4]

BUTLER TC, 1956, P SOC EXP BIOL MED, V93, P544

BUTLER, TC ;

WADDELL, WJ .

[6]

BUTTER AJM, 1953, LANCET, V264, P1024

[7]

CARTELLIERI L, 1956, Med Klin, V51, P986

[8]

CONKLIN J W, 1956, R I Med J, V39, P624

[9] A NOTE ON A URINARY METABOLITE OF PHENOBARBITONE [J].

CURRY, AS .

[10] MYLEPSIN AS AN ANTI-EPILEPTIC DRUG [J].

DREYER, R .